{"id":2387,"date":"2021-08-12T18:53:00","date_gmt":"2021-08-12T18:53:00","guid":{"rendered":"https:\/\/lykan.dsstaging2.com\/?p=2387"},"modified":"2022-05-27T21:51:22","modified_gmt":"2022-05-27T21:51:22","slug":"lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization","status":"publish","type":"post","link":"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/","title":{"rendered":"Lykan Bioscience Partners with Vineti to Advance Cell-based Therapies from Clinical to Commercialization"},"content":{"rendered":"\n

<\/p>\n\n\n\n

Lykan Bioscience\u2019s world-class manufacturing facility, integrated with Vineti\u2019s leading digital enterprise platform for cell and gene therapy supply chains, will streamline process development and manufacturing to deliver these therapies to patients in need<\/strong><\/p>\n\n\n\n

<\/p>\n\n\n\n

HOPKINTON, MA and SAN FRANCISCO, CA, Aug 12, 2021<\/strong> \u2014 Lykan Bioscience, a contract development and manufacturing organization (CDMO) focused on cell-based therapies, and Vineti<\/a>, the world\u2019s only enterprise software platform supporting supply chain orchestration for clinical and commercial cell therapies, today announced a partnership to unite Lykan\u2019s purpose-built facility and Vineti\u2019s industry-leading supply chain and data management system. The partnership empowers biopharma customers with optimized manufacturing efficiency and a complete solution to bring cell-based, life-saving therapies to patients in need.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Advanced therapies, such as cell therapies, require advanced infrastructure. Legacy systems managing the production of cell therapies are often manual and outdated, slowing the scale, speed, and patient safety during development. The cell therapy industry requires a new level of visibility, detail, and access across each product and facility within the supply chain. Lykan and Vineti\u2019s global, non-exclusive partnership between two leading innovators in the Cell Therapy space will ensure Chain of Identity (COI) and Chain of Custody (COC)<\/a> visibility as therapies go through each step in the manufacturing supply chain, bringing patient safety back to the forefront.<\/p>\n\n\n\n

<\/p>\n\n\n\n

\u201cAt Lykan, our mission is to be an innovative manufacturer of cell therapy products. We strive to help our biopharma partners achieve a rapid transition from clinical to commercial manufacturing and maximize patient access to cell therapies. The complex nature of cell therapy process development and manufacturing means our partners need innovative technologies, a reliable platform and strong manufacturing expertise to deliver safe and effective therapies,\u201d said Lykan President and CEO Patrick Lucy<\/a>. \u201cOur strategic partnership with Vineti aims to enable our partners\u2019 success with faster and simpler operations using a more robust and traceable control system.\u201d<\/p>\n\n\n\n

<\/p>\n\n\n\n

Lykan Bioscience has established a world-class, purpose-built, multi-product cell therapy manufacturing facility<\/a> just outside of Boston, Massachusetts. Advanced and integrated software systems, such as Vineti\u2019s Personalized Therapy Management\u00ae (PTM) platform, a proven purpose-built, enterprise-grade digital solution for advanced therapy data and supply chains, will enable Lykan to conduct real-time monitoring of the manufacturing process and
product, complete with electronic batch records that will support real-time testing and release of product from each of Lykan\u2019s eight clinical and commercial cGMP manufacturing suites.<\/p>\n\n\n\n

<\/p>\n\n\n\n

\u201cCell therapies are at a point where they require a truly world-class, purpose-built, multiproduct cell therapy manufacturing facility, with the best digital tools, allowing for true connectivity across the ecosystem,\u201d said Vineti CEO and Co-founder Amy DuRoss. \u201cWe are thrilled to partner with Lykan Bioscience to ensure COI and COC visibility as therapies go through each step in the supply chain, to efficiently deliver these therapies to the patients that need them, faster.”<\/p>\n\n\n\n

<\/p>\n\n\n\n

This partnership follows Lykan\u2019s recent announcement on the hiring of the company\u2019s new CTO<\/a> and Vineti\u2019s release of its PTM Essentials\u2122 solution for clinical-phase advanced therapies. More information on the Lykan-Vineti solution is available through both company\u2019s business development teams.<\/p>\n\n\n\n

<\/p>\n\n\n<\/a>\r\n

\r\n
\r\n \r\n\t
Learn how Lykan
can work with you<\/div>\r\n\t\r\n\t \r\n \r\n Why Lykan\u202f <\/span>\r\n <\/use><\/svg><\/span>\r\n <\/a>\r\n\t\r\n <\/div>\r\n<\/div>\r\n\r\n\r\n\n\n\n

<\/p>\n\n\n\n

About Lykan Bioscience<\/strong><\/p>\n\n\n\n

<\/p>\n\n\n\n

Lykan Bioscience is a contract development and manufacturing services organization (CDMO) focused on cell-based therapies. With decades of biopharmaceutical industry experience, Lykan offers a full range of development and manufacturing services. The state-of-the-art, purpose-built facility offering eight independent manufacturing suites is uniquely designed to fully integrate cGMP principles and advanced software solutions to enable real-time testing and release of product. Located in Hopkinton, Massachusetts, 25 miles southwest of downtown Boston and in the proximity of three international airports, Lykan Bioscience is ideally situated to deliver life-saving cell therapy treatments to patients on behalf of their partners. Visit www.lykanbio.com<\/p>\n\n\n\n

<\/p>\n\n\n\n

About Vineti<\/strong><\/p>\n\n\n\n

<\/p>\n\n\n\n

Vineti offers the first commercial, configurable cloud-based platform to expand patient access to life-saving cell and gene therapies. Vineti was co-founded by GE and the Mayo Clinic to solve the key challenges that patients, medical providers, biopharmaceutical companies, and regulators face in the delivery and commercialization of individualized therapies. Now a fully independent company, Vineti offers a digital platform of record to integrate logistics, supply
chain management, manufacturing, and clinical data for personalized therapies. The Vineti Personalized Therapy Management\u00ae (PTM) platform aligns and orchestrates the advanced therapy process and improves product performance overall, supporting the full continuum of patient-specific therapies, including personalized cancer vaccines and autologous and allogeneic cell and gene therapies. Vineti is currently serving patients, healthcare providers, and researchers in hundreds of leading medical centers and manufacturing centers worldwide on behalf of a growing number of biopharmaceutical partners. In 2019, the World Economic Forum honored Vineti as a World Economic Forum Technology Pioneer. Vineti is headquartered in San Francisco, California, with teams based in the Washington, D.C. area and Yerevan, Armenia. For more information, please visit http:\/\/vineti.com.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Media Contacts<\/strong><\/p>\n\n\n\n

<\/p>\n\n\n\n

Lykan Bioscience<\/strong><\/p>\n\n\n\n

Director of Marketing
Carrie Zhang
carrie.zhang@lykanbio.com
<\/p>\n\n\n\n

Vineti<\/strong><\/p>\n\n\n\n

1AB Media for Vineti
Dan Budwick
dan@1abmedia.com<\/p>\n","protected":false},"excerpt":{"rendered":"

Lykan Bioscience\u2019s world-class manufacturing facility, integrated with Vineti\u2019s leading digital enterprise platform for cell and gene therapy supply chains, will streamline process development and manufacturing to deliver these therapies to patients in need HOPKINTON, MA and SAN FRANCISCO, CA, Aug 12, 2021 \u2014 Lykan Bioscience, a contract development and manufacturing organization (CDMO) focused on cell-based…<\/p>\n","protected":false},"author":5,"featured_media":3480,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[9],"tags":[26],"acf":[],"yoast_head":"\r\nLykan Bioscience Partners with Vineti to Advance Cell-based Therapies from Clinical to Commercialization - Lykan Bioscience<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Lykan Bioscience Partners with Vineti to Advance Cell-based Therapies from Clinical to Commercialization - Lykan Bioscience\" \/>\r\n<meta property=\"og:description\" content=\"Lykan Bioscience\u2019s world-class manufacturing facility, integrated with Vineti\u2019s leading digital enterprise platform for cell and gene therapy supply chains, will streamline process development and manufacturing to deliver these therapies to patients in need HOPKINTON, MA and SAN FRANCISCO, CA, Aug 12, 2021 \u2014 Lykan Bioscience, a contract development and manufacturing organization (CDMO) focused on cell-based...\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/\" \/>\r\n<meta property=\"og:site_name\" content=\"Lykan Bioscience\" \/>\r\n<meta property=\"article:published_time\" content=\"2021-08-12T18:53:00+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2022-05-27T21:51:22+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/ms.ragersoul.com\/lykan\/wp-content\/uploads\/sites\/5\/2021\/08\/partnership-logo.jpg\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\r\n\t<meta property=\"og:image:height\" content=\"667\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ms.ragersoul.com\/lykan\/#website\",\"url\":\"https:\/\/ms.ragersoul.com\/lykan\/\",\"name\":\"Lykan Bioscience\",\"description\":\"Transforming the Future Together\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ms.ragersoul.com\/lykan\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/ms.ragersoul.com\/lykan\/wp-content\/uploads\/sites\/5\/2021\/08\/partnership-logo.jpg\",\"contentUrl\":\"https:\/\/ms.ragersoul.com\/lykan\/wp-content\/uploads\/sites\/5\/2021\/08\/partnership-logo.jpg\",\"width\":1200,\"height\":667,\"caption\":\"Vineti and Lykan Bioscience logos.\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/#webpage\",\"url\":\"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/\",\"name\":\"Lykan Bioscience Partners with Vineti to Advance Cell-based Therapies from Clinical to Commercialization - Lykan Bioscience\",\"isPartOf\":{\"@id\":\"https:\/\/ms.ragersoul.com\/lykan\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/#primaryimage\"},\"datePublished\":\"2021-08-12T18:53:00+00:00\",\"dateModified\":\"2022-05-27T21:51:22+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ms.ragersoul.com\/lykan\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lykan Bioscience Partners with Vineti to Advance Cell-based Therapies from Clinical to Commercialization\"}]},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/ms.ragersoul.com\/lykan\/author\/\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lykan Bioscience Partners with Vineti to Advance Cell-based Therapies from Clinical to Commercialization - Lykan Bioscience","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/","og_locale":"en_US","og_type":"article","og_title":"Lykan Bioscience Partners with Vineti to Advance Cell-based Therapies from Clinical to Commercialization - Lykan Bioscience","og_description":"Lykan Bioscience\u2019s world-class manufacturing facility, integrated with Vineti\u2019s leading digital enterprise platform for cell and gene therapy supply chains, will streamline process development and manufacturing to deliver these therapies to patients in need HOPKINTON, MA and SAN FRANCISCO, CA, Aug 12, 2021 \u2014 Lykan Bioscience, a contract development and manufacturing organization (CDMO) focused on cell-based...","og_url":"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/","og_site_name":"Lykan Bioscience","article_published_time":"2021-08-12T18:53:00+00:00","article_modified_time":"2022-05-27T21:51:22+00:00","og_image":[{"width":1200,"height":667,"url":"https:\/\/ms.ragersoul.com\/lykan\/wp-content\/uploads\/sites\/5\/2021\/08\/partnership-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Written by":"","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/ms.ragersoul.com\/lykan\/#website","url":"https:\/\/ms.ragersoul.com\/lykan\/","name":"Lykan Bioscience","description":"Transforming the Future Together","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ms.ragersoul.com\/lykan\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/#primaryimage","inLanguage":"en-US","url":"https:\/\/ms.ragersoul.com\/lykan\/wp-content\/uploads\/sites\/5\/2021\/08\/partnership-logo.jpg","contentUrl":"https:\/\/ms.ragersoul.com\/lykan\/wp-content\/uploads\/sites\/5\/2021\/08\/partnership-logo.jpg","width":1200,"height":667,"caption":"Vineti and Lykan Bioscience logos."},{"@type":"WebPage","@id":"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/#webpage","url":"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/","name":"Lykan Bioscience Partners with Vineti to Advance Cell-based Therapies from Clinical to Commercialization - Lykan Bioscience","isPartOf":{"@id":"https:\/\/ms.ragersoul.com\/lykan\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/#primaryimage"},"datePublished":"2021-08-12T18:53:00+00:00","dateModified":"2022-05-27T21:51:22+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ms.ragersoul.com\/lykan\/lykan-bioscience-partners-with-vineti-to-advance-cell-based-therapies-from-clinical-to-commercialization\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ms.ragersoul.com\/lykan\/"},{"@type":"ListItem","position":2,"name":"Lykan Bioscience Partners with Vineti to Advance Cell-based Therapies from Clinical to Commercialization"}]},{"@type":"Person","@id":"","url":"https:\/\/ms.ragersoul.com\/lykan\/author\/"}]}},"_links":{"self":[{"href":"https:\/\/ms.ragersoul.com\/lykan\/wp-json\/wp\/v2\/posts\/2387"}],"collection":[{"href":"https:\/\/ms.ragersoul.com\/lykan\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ms.ragersoul.com\/lykan\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ms.ragersoul.com\/lykan\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/ms.ragersoul.com\/lykan\/wp-json\/wp\/v2\/comments?post=2387"}],"version-history":[{"count":0,"href":"https:\/\/ms.ragersoul.com\/lykan\/wp-json\/wp\/v2\/posts\/2387\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ms.ragersoul.com\/lykan\/wp-json\/wp\/v2\/media\/3480"}],"wp:attachment":[{"href":"https:\/\/ms.ragersoul.com\/lykan\/wp-json\/wp\/v2\/media?parent=2387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ms.ragersoul.com\/lykan\/wp-json\/wp\/v2\/categories?post=2387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ms.ragersoul.com\/lykan\/wp-json\/wp\/v2\/tags?post=2387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}